← FDA Drug Approvals (Drugs@FDA)

NDA218193

NDA · New Drug Application · Sponsor: MYLAN PHARMS INC · Approved 2023-08-16

Drug application

FDA Application #

NDA218193

Application type

New Drug Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

MYLAN PHARMS INC

First approval

2023-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown